Ocugen (OCGN) Accumulated Expenses (2014 - 2026)
Ocugen (OCGN) posted Accumulated Expenses of $11.6 million for Q1 2026, down 21.18% on a QoQ basis from $14.7 million in Q4 2025, and down 10.17% year-over-year from $12.9 million in Q1 2025.
Ocugen (OCGN) Accumulated Expenses (2014 - 2026) Analysis & Trends
Ocugen's Accumulated Expenses history runs 13 years deep, the most recent figure standing at $11.6 million for Q1 2026.
- Quarterly Accumulated Expenses fell 10.17% year-over-year to $11.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.6 million (down 10.17% YoY) and the FY2025 annual result came in at $14.7 million, down 4.95% from the prior year.
- Accumulated Expenses was $11.6 million for Q1 2026 at Ocugen, down from $14.7 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $20.0 million in Q4 2022 and bottomed at $9.2 million in Q1 2022.
- A 5-year average of $14.3 million and a median of $13.3 million in 2023 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Accumulated Expenses surged 361.76% — and 2023, when it tumbled 33.19%.
- Ocugen's Accumulated Expenses stood at $20.0 million in 2022, then tumbled by 33.19% to $13.3 million in 2023, then climbed by 16.17% to $15.5 million in 2024, then retreated by 4.95% to $14.7 million in 2025, then dropped by 21.18% to $11.6 million in 2026.
- Business Quant data shows OCGN's Accumulated Expenses at $11.6 million in Q1 2026, $14.7 million in Q4 2025, and $14.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ocugen | 63.79 Mn | 63.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.61 Mn |
| Dec 31, 2025 | 14.73 Mn |
| Sep 30, 2025 | 14.93 Mn |
| Jun 30, 2025 | 12.90 Mn |
| Mar 31, 2025 | 12.93 Mn |
| Dec 31, 2024 | 15.50 Mn |
| Sep 30, 2024 | 12.48 Mn |
| Jun 30, 2024 | 12.81 Mn |
| Mar 31, 2024 | 12.43 Mn |
| Dec 31, 2023 | 13.34 Mn |
| Sep 30, 2023 | 14.99 Mn |
| Jun 30, 2023 | 18.83 Mn |
| Mar 31, 2023 | 16.72 Mn |
| Dec 31, 2022 | 19.97 Mn |
| Sep 30, 2022 | 17.62 Mn |
| Jun 30, 2022 | 11.73 Mn |
| Mar 31, 2022 | 9.15 Mn |
| Dec 31, 2021 | 4.33 Mn |
| Sep 30, 2021 | 3.96 Mn |
| Jun 30, 2021 | 3.87 Mn |